Recently, it has been reported that constitutional monoallelic methylation of the MLH1 promoter can cause the silencing of that allele by a mechanism of transcriptional downregulation, which is cancer-predisposing and should be considered as a cause of LS and managed in the same ways as LS with sequence variants in MLH1 (45). The gene discussed is MLH1; the disease is cancer.